Loading…
Loading…
Grey-scale and power Doppler assessment of synovitis, effusion, and erosions
Musculoskeletal ultrasound (MSUS) has emerged as an indispensable point-of-care tool in rheumatology practice, enabling real-time assessment of synovial inflammation, joint effusion, tendon pathology, and crystal deposition without radiation exposure. At Dr. Shree Narayan's clinic, MSUS is used for diagnostic assessment (differentiating inflammatory from mechanical joint disease), guided aspiration and injection (improving accuracy to greater than 95%), and monitoring treatment response (quantifying subclinical synovitis and power Doppler activity). Grey-scale ultrasound detects synovial hypertrophy and effusion, while power Doppler ultrasound identifies active neovascularisation correlating with histological synovitis and predicting structural progression.
Kathmandu Neurology Clinic & Cognitive Center
Authored and reviewed by Dr. Shree Narayan Yadav (MBBS (KU), MD-Internal Medicine (NAMS), MSc Clinical Rheumatology (USW, UK), NMC 14227). Evidence-based, no fabricated outcomes.
Musculoskeletal ultrasound (MSUS) has emerged as an indispensable point-of-care tool in rheumatology practice, enabling real-time assessment of synovial inflammation, joint effusion, tendon pathology, and crystal deposition without radiation exposure. At Dr. Shree Narayan's clinic, MSUS is used for diagnostic assessment (differentiating inflammatory from mechanical joint disease), guided aspiration and injection (improving accuracy to greater than 95%), and monitoring treatment response (quantifying subclinical synovitis and power Doppler activity). Grey-scale ultrasound detects synovial hypertrophy and effusion, while power Doppler ultrasound identifies active neovascularisation correlating with histological synovitis and predicting structural progression.
Reviewed by Dr. Shree Narayan Yadav, MBBS, MD, MSc — Consultant Physician & Joint and Autoimmune Disease Specialist (NMC 14227), Kathmandu Neurology Clinic. For evaluation, book an appointment.
Grey-scale MSUS assessment of joints evaluates synovial hypertrophy (abnormal hypoechoic tissue within the joint that is non-displaceable and poorly compressible), joint effusion (anechoic or hypoechoic material that is compressible and displaceable), and bony erosions (cortical discontinuity visible in two perpendicular planes). The EULAR-OMERACT scoring system (0-3 semi-quantitative scale) grades synovitis across multiple joints. Power Doppler ultrasound detects increased blood flow in inflamed synovium (neovascularisation), providing a direct measure of active inflammation that correlates with histological vascularity and predicts radiographic progression.
Ultrasound-guided joint aspiration and injection significantly improves accuracy compared with landmark-based techniques, with studies demonstrating accuracy rates exceeding 95% for knee, shoulder, and hip injections compared with 70-80% for blind techniques. MSUS also enables real-time crystal identification in acute arthritis: monosodium urate crystals appear as hyperechoic fibrillar deposits within synovial fluid or as a hyperechoic line over articular cartilage (double contour sign in gout), while calcium pyrophosphate crystals appear as hyperechoic foci within fibrocartilage (chondrocalcinosis). Tendon assessment includes rotator cuff evaluation (supraspinatus, infraspinatus), Achilles tendon pathology, and plantar fascia assessment.
Serial MSUS assessment enables objective monitoring of treatment response by quantifying changes in synovial hypertrophy and power Doppler activity over time. Research demonstrates that power Doppler activity at the end of RA induction therapy predicts relapse after DMARD withdrawal, supporting MSUS as a tool for treatment personalisation. Subclinical synovitis (power Doppler positive but clinically quiescent joints) is present in up to 40% of RA patients in apparent remission and predicts structural progression, suggesting that MSUS can identify patients who may benefit from continued therapy. Erosion progression can also be tracked longitudinally with MSUS, though MRI remains superior for early erosion detection.
Guidelines referenced:
Backhaus M et al. EULAR-OMERACT rheumatoid arthritis ultrasound scoring system. Ann Rheum DisNaredo E et al. Value of musculoskeletal ultrasound in the management of rheumatic diseases. Arthritis RheumatolSchellekens GA et al. MSUS in rheumatoid arthritis: diagnostic accuracy, monitoring, and structural prediction. RheumatologyContent on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.